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Versatile Sarcosine Biosensing Schemes Utilizing Layer-by-Layer
Construction of Carbon Nanotube-Chitosan Composite Films
Michael J. Pannell, Elizabeth E. Doll, Najwa Labban, Mulugeta B. Wayu, Julie A. Pollock,* and
Michael C. Leopold*
Abstract
Layer-by-layer composite films of carbon nanotubes (CNTs) within a chitosan matrix with
sarcosine oxidase enzyme and capped with Nafion have been developed and optimized as a
versatile 1 generation amperometric sarcosine biosensing platform that operates successfully both
as an isolated sarcosine sensor as well as a functional component within a creatinine sensor.
Accurate measurement of sarcosine in urine and creatinine in blood may help with early diagnosis
of diseases such as prostate cancer and renal failure, respectively. In this study, each material
within the film is systematically optimized toward sarcosine sensitivity, including a critical
evaluation of different CNTs effect on sensing performance. Films featuring carboxylic acid–
modified single–walled carbon nanotubes and strategic enzyme doping were shown to be most
effective sarcosine sensing platforms, exhibiting excellent sensitivity (~0.5 µA/mM), a linear
response (≤ 0.75 mM), fast response time (8 s), low limits of detection (~6 µM), as well as both
continuous use stability (7 days) and effective shelf life (> 12 days). Operation of the sarcosine
sensor was demonstrated in a urine matrix, detecting sarcosine at physiologically relevant
concentrations and successfully quantifying sarcosine-spiked urine samples with high percent
recovery and low relative error. The sarcosine sensing platform was also adapted to a 1 generation
creatinine biosensing scheme in which the sarcosine enzymatic reaction is critical to a trienzymatic cascade event. The creatinine sensor yielded sensitivity of ~0.6 µA/mM, similar
sensing performance parameters to the sarcosine sensor, and was effectively operated in blood
serum at physiologically relevant creatinine concentrations. The demonstrated functionality of
these sensors in their respective biological fluids at physiological concentrations of the analyte
species suggests potential clinical application as diagnostic tools.
st

st

NAFION

+

SOx

I
i

CNT-CS

Pt 2e-

t

Graphical Abstract
____________________________________________________
* To whom correspondence should be addressed. Dual corresponding authors. Email:
mleopold@richmond.edu: Phone: (804) 287–6329 (MCL) or jpollock@richmond.edu: (804) 484–1578
(JAP). Fax: (804) 287–1897

1

For submission to J. Electroanalytical Chemistry
1. Introduction
Sarcosine is an intermediate in the metabolism of methionine and a by–product in the
synthesis and degradation of glycine [1]. As an amino acid derivative, sarcosine serves as a
metabolic precursor to many different types of cellular molecules, such as creatine and serine.
Preliminary studies have indicated that sarcosine has promise as a possible adjuvant for the
treatment of mental illnesses, such as depression and schizophrenia [2, 3]. Sarcosine is also an
intermediate in the enzymatic degradation of creatinine and creatine, the former an indicator
molecule for the presence of muscular degradation, kidney disease, and possible renal failure [4].
In addition, increased sarcosine levels have been attributed to the development of prostate cancer
[5-8]. Specifically related to prostate cancer, current medical diagnosis involves the determination
of prostate–specific antigen (PSA), a protein directly linked to the presence of prostate cancer.
However, the determination of PSA as an indicator for prostate cancer has historically led to over–
diagnoses and unreliable results, requiring the use of more invasive procedures, most notably
biopsy [9]. With the increased recognition of the importance of sarcosine and its metabolic
precursors for potential diagnosis purposes, the scope of sensor development research has also
expanded, including both electrochemical [8,10] and spectroscopic [7] strategies. Innovative
systems are increasing targeting sarcosine, including recent developments with polymer
imprinting [7] and colorimetric assay methods [9, 11]. As such, the need for a sarcosine sensor
that is accurate, sensitive, and adaptable to on-site application with widespread use while not
requiring costly fabrication or complex instrumentation remains an important goal.
Biosensors featuring electrochemical detection of targeted analyte species offer many of
the attributes desired in diagnostic sensors and have extensively explored this possibility for a
number of different analytes [12]. In order to ensure selectivity with electrochemical systems,
oxidase enzyme–based biosensors offer a viable strategy due to their high specificity toward target
analyte as well as their ability to be immobilized onto a surface or within a matrix. Hydrogen
peroxide, a by–product of enzyme-catalyzed reactions between target analyte and oxygen, is
subsequently oxidized at an electrode surface, creating a reliable amperometric signal directly
proportional to analyte concentration. These 1 generation amperometric biosensors have shown
st

success, both with a glucose model system as well as other clinically relevant tested analytes, such
as uric acid [13]. While these systems excel in terms of simplicity and affordability, the ability to
2
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adapt these systems to respond to numerous analytes through minimal modification is of particular
interest for clinical applications, including the potential to miniaturize the sensors to wire
electrodes .
Amperometric biosensing schemes are typically designed to target molecules that are
abundant in biological fluids (e.g., amperometric glucose biosensors aim for mM detection levels).
As a sensing target, sarcosine is clinically relevant at relatively low concentrations and highlights
the need for a more sensitive detection platform. As typical with all biosensor schemes, the signal
from a working electrode can be depressed in attempts to provide selectivity to a system by
modifying the electrode with functional layers [14]. The use of chitosan as a scaffolding material
has been widely researched and integrated into biosensing schemes; the material has many positive
attributes: biocompatibility, effective adhesion and absorption onto electrode surfaces, high
affinity for aqueous solutions, the ability to incorporate nanomaterials, as well as a chemical
structure amenable to synthetic modification at the projected hydroxyl and amino functional
groups [15-20].
The incorporation of carbon nanotubes (CNTs) specifically into the chitosan matrix has
been of general interest due to their conductive and catalytic properties aimed at enhancing the
generally non–conductive chitosan matrix [20]. Multiple methods of incorporation have been
studied, including covalently attaching the nanotubes directly to the chitosan matrix as
demonstrated by Carson et al. (2009) [21]. However, modification of CNTs was determined to
create more defect sites, resulting in lower conductivity and diminished returns in terms of
nanotube incorporation [21]. The incorporation of nanomaterials, including CNTs as well as gold
colloidal nanoparticles, all of which have unique properties regarding their conductivity,
interactions with biological materials, and surface area–to–volume ratio, have been shown to
enhance amperometric–based signals at electrode interfaces [14, 22-24]. The collective body of
work suggests that nanomaterials provide a convenient solution to the trade–off between
sensitivity and selectivity due their stability within a scaffolding material, which would
simultaneously immobilize an oxidase enzyme and any stabilizing agents needed. The lower
concentrations of sarcosine relative to other typical analytes give special interest into these signal
enhancement strategies and materials.

3
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Previous works have found success with the use of sarcosine oxidase (SOx), an enzyme
that catalyzes the reaction:
𝑆𝑎𝑟𝑐𝑜𝑠𝑖𝑛𝑒 + 𝐻- 𝑂 + 𝑂- → 𝐹𝑜𝑟𝑚𝑎𝑙𝑑𝑒ℎ𝑦𝑑𝑒 + 𝐺𝑙𝑦𝑐𝑖𝑛𝑒 + 𝐻- 𝑂-

(1)

often times coupled with the enzymatic reactions of creatininase (CA) and creatinase (CI) [25, 26].
It is notable that one the most important applications of a sarcosine sensor to consider is its ability
to function within schemes designed to detect creatininase. While some reports have found success
with direct adsorption of SOx on the electrode surface [4], immobilization within a layer–by–layer
(LbL) system provides a more intuitive solution for the inclusion of SOx, nanomaterials, and other
stabilizing agents previously explored within other systems.
In this work, a LbL approach towards sarcosine detection involving carboxylic acid
functionalized carbon nanotube–chitosan nanocomposite films as a scaffold for an enzymatic layer
terminated with a Nafion binding layer is demonstrated. While individual sensor reports utilizing
CNTs are found throughout the literature, our study separates itself in identifying the properties of
the nanomaterials that exert more influence in an effective sarcosine electrochemical sensor.
Additionally, after exploring different CNT materials and optimizing the functional ad–layers, the
performance of the developed biosensor system is evaluated for sensitivity, selectivity, stability
and functionality in relevant bodily fluid samples. Because sarcosine sensing is critical within the
indirect detection of creatinine, the sensor developed herein is also assessed as a functional
component of a creatinine-sensing scheme. Ultimately, the attributes of our sensing scheme are
compared to a very limited number of electrochemical sarcosine sensor reports in the literature [4,
27-31] in order to emphasize the potential promise of this approach for further development toward
clinical application.

2. Experimental Section
2.1. Materials and instrumentation
All chemicals were purchased from Sigma–Aldrich unless specifically stated. Nafion (Liquion
solution LQ–1105 1100EW 5% wt. and D2021 20% wt.) was purchased from Ion Power, Inc.
(New Castle, DE, USA). Pristine and carboxylic acid functionalized single–walled carbon
4
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nanotubes (p–SWCNTs and COOH–SWCNTs) were purchased from NanoLab, Inc. (Waltham,
MA, USA). Creatininase enzyme was purchased from BBI Solutions (> 500 U/mg), synthetic urine
(Surine) from Cerilliant (Sigma-Aldrich), and blood serum (sheep) from Hemostat. Ultra–purified
water (UP H O, 18.3 MΩ cm) was used to prepare all solutions. An eight–channel potentiostat (CH
2

Instruments, 1000B) was used to record amperometric current–time (I–t) curves to evaluate the
analytical performance of the sensors, as described below. Electrochemical cells were comprised
of a common Ag/AgCl (saturated KCl) reference electrode, a common platinum wire counter
electrode (Sigma–Aldrich), and modified platinum working electrodes (2mm diameter, CH
Instruments). An FT-IR ATR spectrophotometer (Thermo Scientific-Nicolet iS10) was used to
characterize either drop-cast (e.g., chitosan solution) or powder (e.g., CNT) samples.

2.2. Sarcosine Oxidase
Protein Expression. The plasmid vector pET–21a encoding for SOx (Genscript) was transformed
into chemically competent E. coli BL21 (DE3) Star cells (Invitrogen) to express SOx. The
transformed Star cells were grown in an overnight culture with 10 mL of terrific broth,
supplemented with ampicillin (100 µg/mL). Terrific broth (250 mL) + AMP (100 µg/mL) cultures
were inoculated with 2.5 mL of overnight culture. The cultures were then incubated with shaking
at 37 ℃ until they reached an OD of 0.5–0.6. At this point, protein expression was induced with
600

IPTG to a final concentration of 0.1 mM and incubated with shaking for 3 hours at 37℃.
Afterwards, the cells were harvested by centrifugation at 4,000 rpm for 30 minutes at 4℃. The
pellets were stored at –20℃.
Protein Purification. Cell pellets were re–suspended in 4 mL of lysis equilibration buffer (50 mM
NaPi, 200 mM NaCl, 5 mM imidazole, pH 7.6), supplemented with PMSF (0.5 mM). Cells were
lysed by sonication, then centrifuged at 12,000 rpm for 30 minutes at 4℃ to remove cellular debris.
The crude lysate was purified using a Ni–NTA affinity column. The column was charged with
NiCl (50 mM) and equilibrated with lysis buffer (50 mM NaPi, 200 mM NaCl, 5 mM imidazole,
2

pH 7.6). The cell lysate was added to the column and washed with wash buffer 1 (50 mM NaPi,
200 mM NaCl, 25 mM imidazole, pH 7.6), followed by wash buffer 2 (50 mM NaPi, 200 mM
NaCl, 50 mM imidazole, pH 7.6) Finally, the protein was eluted with elution buffer (50 mM NaPi,
200 mM NaCl, 250 mM imidazole, pH 7.6). The purified SOx was desalted using a 10DG column
5
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(Bio–Rad) into 5 mM phosphate buffer (pH 7.6). This final protein product was analyzed with
SDS–PAGE (Supporting Information, Fig. SI–1) before being lyophilized for 24–72 hours.
Enzyme Activity Assay. A hydrogen peroxide fluorescence assay (Sigma Aldrich) was used to
assess the functionality and activity of the sarcosine oxidase product, following manufacturer
procedures. The assays indicated that the SOx produced in house was fully functional with
adequate activity levels (see Supporting Information, Fig. SI–2).

2.3 Preparation of electrode materials
As previously mentioned, chitosan has been used previously for immobilizing enzymes
and nanomaterials within biosensing schemes [16-19, 21]. This body of work has extensively
characterized the chitosan layers via some combination of UV-Vis, FT-IR and Raman
spectroscopies, electrochemical techniques, and electron microscopies [15-16,18,20-21], though
the latter techniques seem to offer limited information regarding the CS films. Because of the
extent of the CS film characterization available in the literature, exhaustive repetition of all these
techniques was not performed in this study. Rather, readily available electrochemical methods
and FT-IR spectroscopy was used to simply confirm CNT incorporation into the CS films. CS
solution was prepared as previously reported with a slight modification [32]. Briefly, 0.5% wt. CS
solution was prepared using stirring for 1 h in 1.0 % acetic acid. The pH was adjusted to 5.0 using
drops of 1M NaOH solution. CNTs (1 mg) were added into 1 mL of 0.5 % wt. CS solution (pH
5.0), followed by ultrasonication for 2h to form a suspension of CNTs. The mixture was then
separated using centrifugation and the supernatant, comprised of homogeneously dispersed CNTs,
was used as the electrode material. Sarcosine oxidase solutions were prepared by dissolving the
desired amount of SOx in 4.4 mM phosphate buffer solution (PBS), prepared by mixing monoand di- potassium phosphate solutions to desired pH of 7.0.

2.4 Electrode preparation
Platinum electrodes (Pt) were successively polished with 1.0, 0.3, and 0.05 µm alumina
powder (Electron Microscopy Sciences) and rinsed thoroughly with ultrapure water. Then the
electrodes were electrochemically cleaned in 0.1M H SO solution via cyclic voltammetry between
2
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–0.4 and +1.2 V vs Ag/AgCl prior to use. As illustrated in Scheme I, a typical electrode
modification involved a 7.0 µL aliquot of CNT–CS solution being drop–cast on the electrode
surface and allowed to dry in 50% RH controlled chamber for 45 min. to obtain Pt/CNT–CS
modified electrodes that are visibly darker compared to the clean Pt electrodes. Then a 7.0 µL
aliquot of SOx (6 mg/mL) solution was subsequently drop–cast onto the electrode, allowed to dry
(50% RH, 60 min.) to obtain Pt/CNT–CS/SOx modified electrode. Finally, a 7.0 µL aliquot of
Nafion solution was then drop–cast onto that composite film, allowed to dry (50% RH, 10 min.)
to obtain the final Pt/CNT–CS/SOx/Nafion biosensor. The entire process for these and other L-bL combinations of these materials was conducted at room temperature.
For evaluating the sensors, modified electrodes were submerged in 25.0 mL of phosphate
buffer solution (PBS, 4.4 mM, pH 7) stirring at 1100 rpm. The working electrode potential was
held at +0.65 V for 1200 seconds prior to consecutive 25 μL injections of 0.25 M sarcosine stock
solution at 100 seconds intervals. Stair–step amperometric current time responses were produced
as a result of successive 100 µM sarcosine increases. Sensor performance was evaluated using
linear regression analysis of calibration curves. As in prior work, slopes of calibration curves (i.e.,
current response vs. sarcosine concentration) corresponded to sensitivity while response times (t

R–

) were defined as the time required to reach 95% of the total change in current due to an increase

95%

in sarcosine concentration [14, 33].

3. Results and Discussion
The overall design of the enzymatic layer–by–layer (LbL) sarcosine electrochemical
biosensor is depicted in Scheme I, featuring three major components on a platinum electrode
interface: (1) carbon nanotubes–chitosan nanocomposite (CNT–CS) layer; (2) sarcosine oxidase
enzyme (SOx) layer; and (3) an outer Nafion layer. It should be noted that CNT is used as a general
acronym representative of any carbon–based nanomaterial. The following study proceeds by
characterizing the modified electrode, evaluating different nanomaterials as a functional
components of the scheme, optimization of materials within the layered construction, and
culminating with an evaluation of sensor performance, including performance in biological media
(e.g., synthetic urine and blood serum) and as part of a creatinine biosensing scheme as well. The
performance of the sensor is compared and contrasted to literature reports of sensors for both
7
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sarcosine and creatinine. In general, the use of these components as a composite film was shown
to function effectively over a sufficient linear range with high sensitivity, fast response times, and
specific selectivity toward sarcosine in a variety of matrices.
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3.1 Nanocomposite film electrode modification
The characterization of potassium ferricyanide (Fe(CN) ] ) cyclic voltammetry (CV) at
6

3–/4–

modified electrodes remains an effective tool to monitor the progress of adlayers since electron
transfer (ET) occurs either by tunneling through an interface (e.g., ET via tunneling through the
alkane chain of a self-assembled monolayer) or at defects in the interfacial barrier where solution
redox species can access the electrode [34, 35]. In this study, the Fe(CN)

3–/4–
6

redox probe was chosen

to examine changes of electrode surface characteristics upon modification by CS or CNT material.
Figure 1 shows typical CVs and differential pulse voltammetry (DPV) (inset) of Fe(CN)

3–/4–
6

observed at different combinations of the layered materials compared to a bare Pt electrode, the
latter exhibiting expected well–defined oxidation and reduction peaks (Fig. 1a). The introduction
of pristine multi–walled carbon nanotubes (p–MWCNTs) via mixing with the CS material (i.e., p–
MWCNT–CS/Nafion/Pt), showed peak current responses comparatively higher than that at the
bare Pt electrode. The enhanced amperometric response suggests that the p–MWCNT–CS
nanocomposite modified electrodes may benefit from the increased electroactive surface area due
to the incorporation of the CNTs, a result consistent with the conclusions of other reports in the
literature using these materials [20, 36]. Furthermore, the peak–to–peak potential separation
between the cathodic and anodic peaks of the Pt/p–MWCNTs–CS/Nafion is slightly smaller (66

8
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mV) than that of the bare Pt (72 mV), suggesting that the p–MWCNTs–CS are facilitating faster
ET kinetics [37].
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Figure 1: Cyclic voltammetry and
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Differential pulse voltammetry (DPV), a technique that effectively discriminates against
background charging current often observed with CNTs at electrode interfaces, reinforced the CV
results, the CS layer and the CS doped with CNTs both show in an enhancement of the redox
probe’s signal (Fig. 1, inset), consistent with literature [20, 37]. While CNTs, in general, are
known to behave electrocatalytically at electrode interfaces [38], the results suggest that the
incorporation method and type of CNT may play a role in achieving that effect. Also noteworthy,
electrodes modified only with Nafion exhibited severely attenuated voltammetric signals,
suggesting that this layer is somewhat selective against diffusional species in solution (Fig. 1c). In
addition to the electrochemical evidence of successful CNT incorporation at the electrode
interface, the CNT-doped chitosan modified electrodes were all visibly darker than the bare
platinum electrodes.
Infrared spectroscopy (FTIR) was employed as an additional qualitative confirmation of
the successful dispersion of different CNTs within the CS matrices (see Experimental Section 2.1
for method details). Figure 2a displays the characteristic IR spectra of CS films where vibrational
bands for CS film spectra were assigned based on the previously published data [15, 39] including
the broad absorption observed between 3600 cm and 3000 cm being attributed to OH and NH
–1

–1

2

stretching vibrations. Additionally, distinctive NH bending absorptions at 1651 cm , 1557 cm ,
–1

–1

2

1374 cm as well as the symmetric CH stretching vibrations at 2920 and 2871 cm are visible.
–1

–1

Absorption bands at 1149 cm (anti–symmetric stretching of C–O–C bridge), 1061 cm , and 1024
–1

–1
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cm (skeletal vibration involving the C–O stretching) are characteristics of chitosan’s saccharide
–1

structure [39]. If a film of CNT-doped CS material is deposited, these FT-IR signature absorptions
should persist.
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Figure 2: FT-IR spectroscopy characterization of
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Typical IR analysis of most CNTs, regardless of their structural nature (e.g., single vs. multi–
walled or functionalized vs. pristine), reveal broad-band absorption with few features. For
example, Figure 2b is a typical spectrum for unfunctionalized or pristine-multi-walled carbon
nanotubes (p-MWCNT) – relatively featureless with significantly lower % transmittance
compared to the CS film (Fig. 2a). Similar spectra can be collected for p-SWCNT and their
functionalized counterparts as well (shown in Supporting Information, Fig. SI-3). Importantly, the
FT-IR spectra of the p-MWCNT–CS composite film (Figure 2c) shows the persistence of spectral
features of CS, including signature peaks of CS at 3360 cm , 1149 cm and 1024 cm . The
–1

–1

–1

spectroscopy results suggests that the p-MWCNT is successfully incorporated into the CS matrix.
The decrease in transmittance coupled with the spectral signature of CS can be shown in similar
comparisons for COOH functionalized MWCNT, SWCNT, and COOH-SWCNT films with CS as
well (Supporting Information, SI-3). In the case of COOH functionalized CNTs (both MWCNTs
and SWCNTs), the presence of a slight signal at ~1720 cm is attributed to the presence of the
–1
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carbonyl functional group. The weakness of this peak for these materials suggests that there are
low concentrations of carboxylic acid functional groups, most likely localized to the edges of the
tubes [40]. This characteristic peak is notably absent in the pristine SWCNT and MWCNT, which
is similar to previously observed spectra as well [20, 41].
While IR analysis of the materials allows for a qualitative assessment of the CNTs
incorporation within the film, probing voltammetry using Fe(CN)

6

3–/4–

at these interfaces (Figure 3)

is consistent with the spectroscopic characterization presented. Regardless of the type of CNT, all
of the CNT–CS/Nafion modified platinum electrodes exhibited comparatively higher peak
currents for the redox probe than at bare platinum electrodes. As observed in other studies [36, 38,
42, 43], there is an indication that CNT incorporation at an electrode interface results in significant
electrocatalytic activity attributed to an increased electroactive surface area [37]. In this study, as
well as others [37], COOH–SWCNT–CS modified Pt electrodes (Fig. 3A, e) exhibited particularly
higher current response and the smaller peak–to–peak potential separation (57 mV) compared to
bare Pt and CS/Nafion modified electrodes. It should be noted that enhanced current response
obtained with CNTs incorporation was evident regardless of how the voltammetry peaks were
analyzed (i.e., isolating Faradaic current manually or background subtracted voltammetry) (see
Supporting Information, Fig. SI–4 and Table SI–1).
Chronocoulometry (CC) of the Fe(CN)

3–/4–

6

probe was also used in order to experimentally

support the increased effective electroactive surface area believed to be achieved with CNT
incorporation into these films. The electroactive surface areas of the bare Pt, CS and CNT–CS
composite modified Pt were assessed using this methodology where charge (coulombs) as a
function of time (chrono) [44], was employed as previously described [22] to generate an Anson
plot whose slope could be used in equation 2 to calculate A, the electroactive surface area (cm ):
2

𝑄 = 2𝑛𝐹𝐴𝐶𝐷>/-𝜋 A>/-𝑡 >/-

(2)

where Q is the charge passed (C), n is the number of electrons transferred, F is Faraday’s constant
(96,500 C/mole), C is Fe(CN)
coefficient for Fe(CN)

3–/4–
6

concentration (5.00 mM in 0.50 M KCl), D is the diffusion

3–/4–
6

(7.6 x10 cm /s), and t is the time (s). The CC determined electrode areas
–6

2

from all seven interfaces are included in Supporting Information (Fig. SI-4 and Table SI-1) and
indicate that the nearly 4-fold increase in current response observed at COOH-SWCNT-CS
11
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modified electrodes during voltammetry (Fig. 3A) can be directly attributed to an apparent ~3.6fold increase in effective electroactive surface provided by that CNT-doped interface. A summary
of all CC, CV and DPV results are included in the Supporting Information (Table SI–1).

3.2 Evaluation of Nanomaterials for Sarcosine Sensing
The hypothesis of using SWCNTs with COOH functionalization to maximize effective
electroactive surface area was explored by incorporating the various types of CNTs (SWCNT vs.
MWCNTs; pristine vs. COOH–functionalized) into the sarcosine electrochemical biosensor
(Scheme I). That is, each material was incorporated into chitosan solution, deposited at a platinum
electrode with the other layers (SOx enzyme and Nafion), and subsequently evaluated as a
sarcosine biosensing system. Nafion interfaces at electrode surfaces have been previously shown
to be selective for certain analytes [45]. Additionally, prior work in our lab has established that
both pristine and carboxylic acid functionalized MWCNTs when dispersed in Nafion polymer
resulted in enhanced sensitivity in uric acid sensing systems [36, 43].
Sensor constructs featuring MWCNTs were examined during injections of sarcosine.
Common to LbL construction of modified electrodes, initial attempts to utilize these materials
consisted of drop–casting the material directly onto the electrochemically cleaned Pt electrodes.
Figure 3B shows the amperometric I–t curves and the corresponding calibration curves (inset) for
CS films containing p–MWCNT, COOH–MWCNT as well as control systems without CS (i.e.,
SOx enzyme and p–MWCNTs/SOx directly deposited at the electrode and capped with a Nafion
layer). The control experiments, the films lacking the CS scaffold (i.e., Pt/SOx/Nafion and Pt/p–
MWCNT/SOx/Nafion), resulted in extremely poor current responses for sarcosine (i.e., absence
of typical stair–step behavior) and an appraised sarcosine sensitivity of only 0.006 (±0.002)
µA/mM (Fig. 3B, a,b). However, the incorporation of either p–MWCNT or COOH–MWCNTs
within the CS layer, subsequently treated and covered with SOx and Nafion (i.e., Pt/p–MWCNT–
CS/SOx/Nafion and Pt/COOH–MWCNT–CS/SOx/Nafion), showed expected stair–step current
responses and resulted in enhanced sensitivities of 0.08 (±0.00 ) and 0.12 (±0.05) µA/mM,
4

respectively (Fig. 3B, c,d). The use of COOH–functionalized MWCNTs consistently yielded more
defined steps and higher sensitivity, suggesting that the carboxylic acid moieties within the film
may allow for effective engagement and coupling of the nanomaterials with the CS scaffold. This
12
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enhanced response may be due to the amine functional groups on the CS, deposited at pH 5 in this
study, being cationic and possibly interacting with the negatively charged CNTs during the
dispersion process [46].
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Figure 3: (A) Cyclic voltammetry and differential
pulse voltammetry (inset) of 5 mM [Fe(CN) ] (0.5 M
KCl) at (a) bare Pt, and (b) p-MWCNT-CS/Nafion, (c)
COOH-MWCNT-CS/Nafion,
(d)
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concentration was 5% in all cases. Note: Solid symbol
markers indicate a step-like response and, in some
cases, standard error bars are smaller than markers for
average value (n = 3–5).
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With a preliminary result suggesting that the critical component of the sensing scheme may
be the CNTs, additional variations of the material were incorporated with the CS matrix within the
sarcosine biosensing scheme, including both p–SWCNTs and COOH–SWCNTs. SWCNTs are
known for superior electrical conductivity [47]. Figure 3C shows the comparative effects the
various types of CNTs on the electrocatalytic activity of the LbL sarcosine biosensor in terms of
amperometric I–t responses and corresponding calibration curves. Indeed, the correlation between
sensitivity and type of CNT utilized is affirmed. The use of SWCNT in CNT–CS nanocomposites,
regardless of COOH functionalization, resulted in significantly higher sensitivities (0.22 ±0.05
µA/mM and 0.25 ±0.04 µA/mM, respectively) compared to biosensors schemes with the
MWCNTs. The substantial increase in sensitivity may be due to the higher conductivity property
of SWCNT [47]. Additionally, the smaller diameter of the SWCNTs compared to MWCNTs
potentially allows for a greater surface concentration of SWCNTs to be drop–cast onto the
electrode surface in the same deposition volume (i.e., 7 µL); this effect may contribute to the
sensitivity enhancement as well. From the collective findings, COOH–SWCNTs were selected as
the optimal material for this study. Substantial control experiments were conducted where
individual layers or materials (e.g., Nafion, the CNTs, CS) were omitted in the constructs and
tested for sarcosine response. The only systems to yield a stair–step current response with
significant sensitivity toward sarcosine were those systems with all four components: CS with
CNTs, SOx and Nafion (Supporting Information, Fig. SI–6).

3.3. SOx and Nafion Optimization
In order to optimize the performance of the electrochemical biosensor, other parameters
that may affect the electrochemical biosensor activity were examined. To understand the effect of
enzyme concentration, various amounts of SOx, between 2 and 10 mg/mL, in 4.4 mM PBS (pH
7.0) were applied in the sensor design via drop–casting directly onto the optimal COOH–SWCNT–
CS nanocomposite interface. Calibration curves (Figure 4A) generated from corresponding I–t
responses (Supporting Information, Fig. SI–7) show that with lower concentrations of SOx (e.g.,
2 mg/mL), sensitivity is low (0.05 ±0.03 µA/mM). However, as the concentration of SOx was
increased to 4 mg/mL and 6 mg/mL, sensitivity was observed to increase three and nearly six–
fold, respectively. For concentrations beyond 6 mg/mL sensitivity drops off again (~0.16–0.17
14
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µA/mM). The observed decrease in sensitivity at higher SOx concentration may be due to an
increased thickness of the enzyme layer itself hindering the substrate from reaching the active site.
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Figure 4: Calibration curves obtained from the
amperometric I-t curve during successive 0.25 mM
injections of sarcosine at (A) Pt/COOH-SWCNTCS/SOx/Nafion using various concentrations of SOx:
(a) 2 mg/mL, (b) 4 mg/mL, (c) 6 mg/mL, (d) 8 mg/mL
and (e) 10 mg/mL with a summary bar graph of
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was 5% in all cases; (B) Pt/COOH-SWCNTCS/SOx/Nafion with various concentrations of Nafion:
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(inset). Note: Solid symbol markers indicate a step-like
response and, in some cases, standard error bars are
smaller than markers for average value (n = 3–4).
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Similarly, the concentration of the outer Nafion layer was examined by using deposition
solutions of varying concentration, 1 to 10 wt % Nafion in ethanol at the Pt/COOH–SWCNT–
CS/SOx/Nafion system. Figure 4B displays typical calibration curves (I–t responses provided in
Supporting Information, Fig. SI–8) obtained from the application of various Nafion
concentrations. A sensitivity of 0.12 (±0.08) µA/mM was observed when 1% wt. of Nafion was
applied. However, the sensitivity of the electrochemical biosensor was increased ~2.5X when the
concentration of Nafion was increased to 3% wt. Films tested with between 3–5% generally
exhibited baseline noise reduction as well, with 5% Nafion coatings often yielding the lowest
noise. This type of noise reduction has been observed previously when polyurethane [13-14, 36]
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and Nafion [42] have been employed as part of LbL modification of biosensing electrodes. At
Nafion coatings greater than 5%, however, the signal was markedly attenuated and sensitivity
decreased, likely due to the increased thickness of the film hindering the accessibility of the
sarcosine to the detection mechanism.

3.4. Biosensing Performance
The LbL composite films featuring the layers of COOH–SWCNT–CS, 6 mg/mL SOx and
3% wt. Nafion exhibited the highest average sensitivity (0.29 ±0.12 µA/mM ), a dynamic/linear
range up to 1.5 mM sufficient for physiological levels of sarcosine, and a limit of detection (3σ /b
blank

of 13.0 ±0.0

156

1)

µM. Additionally, the optimized sarcosine biosensing system showed an excellent

response time (𝑡DAEF% ) of ~8 seconds, a conservative estimate of the response where the time is
measured once 95% of the total current change is achieved [14, 33]. As part of evaluating system
performance, the selectivity or influence of interfering species on the detection of sarcosine was
investigated. Selectivity assessment of Pt/COOH–SWCNT–CS/SOx/Nafion electrochemical
biosensor is shown in Fig. 5A where the complete film is subjected to injections of common
interferents, along with sarcosine, to reaffirm sensitivity toward analyte in the presence of
interfering species. As seen in the I–t curves (Fig. 5A), injections of the most common interfering
species, urea and creatinine, did not result in significant current responses (0.25 ±0.01 nA and 0.35
±0.01 nA, respectively) relative to the observed average sarcosine current response (298.0 ±0.2
nA) which is order of magnitude higher. Similar insignificant current responses an order of
magnitude smaller than at the compiled films were observed for the interferents at bare platinum
electrodes (Supporting Material, Fig. SI-9), suggesting that the compounds may be gaining minor
access to the electrode through the films.
As has been done in previous studies [14, 33, 48, 49], selectivity coefficients (K ) can be
amp

used to conservatively and quantitatively assess selectivity using the following equation:
JKL

𝐾I
where ∆I and ∆I
j

sarcosine

= log P

∆RS ⁄TS
∆RVWXYZ[\]^ ⁄TVWXYZ[\]^

(3)

_

are the measured step currents for a specific interferent species (j) and

sarcosine (see Supporting Material for specific current measurements) and C and C
j
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concentrations of the interferent species and sarcosine, respectively. Selectivity coefficients are
useful when evaluating sensors because they allow for a normalized concentration comparison of
analyte signal versus interferent response. Negative selectivity coefficients indicate that the
interferent is inconsequential whereas species with positive values are indicative of the selective
species. Fig. 5A (inset) displays a graphical comparison of initial (Day 0) selectivity coefficients
of +0.21, –2.91, and –3.31 calculated for sarcosine, urea, and creatinine, respectively, for the
Pt/COOH–SWCNT–CS/SOx/Nafion biosensing system. The selectivity coefficient for sarcosine
is measured comparing the response of the 0.25 mM injection to that of a three-fold higher
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Figure 5: (A) Typical amperometric I-t curves of
Pt/COOH-SWCNT-CS/SOx/Nafion electrochemical
biosensor during injections of common interferent
species and sarcosine and a graphical summary (inset)
of selectivity coefficients for urea and creatinine on
day 0 and day 9. (n = 6). Note: Day 9 I-t is offset by 50
nA for viewing; (B) Day-to-day (continuous use) and
shelf life (single use) sensitivity tracking for a set (n=4)
of
sarcosine
biosensors (Pt/COOH-SWCNTCS/SOx/Nafion).
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As part of their sensing performance, the stability of the sarcosine biosensors functionality
over time was evaluated in two important ways. First, the sensors were evaluated for continuous
use stability, where sensitivity toward sarcosine for a set of the same electrodes was monitored
day-to-day. The recorded sensitivity of the same set of sensors undergoing daily testing revealed
general stability for at approximately one week before degradation was observed (i.e., lower
sensitivity) – Fig. 5B. While sensitivity did eventually degrade over the course of twelve days, the
sensors remained remarkably selective for sarcosine in the presence of urea and creatinine during
the same timeframe, yielding selectivity coefficients of +0.11, –3.28, and –3.27 at day 9,
respectively (Fig.5A, inset).
However, given the nature of the targeted sarcosine–related illnesses (e.g., prostate cancer)
and the type of physiological samples readily available from patients seeking diagnosis (e.g., urine
and blood), continuous measurement of sarcosine in vivo is not as desirable as with other analytes
such as glucose (diabetes) or uric acid (pregnancy–induced hypertension/preeclampsia risk) [14,
36, 43]. Similarly, the stability of reusing the same electrodes for repeated, day-to-day sarcosine
measurements is of less significance. It is much more relevant to test the shelf–life sensitivity of
individual sensors that would be employed for single measurements of bodily fluids samples. More
specifically, and in contrast to the aforementioned daily or continuous testing, a number of
electrodes were fabricated on the same day and stored. Each day a new, previously unused (i.e.,
aged) composite film was evaluated for sarcosine sensitivity. The results of the shelf–life
assessment (Fig. 5B) indicate that sensors, stored at 7-8°C and aged up to nearly two weeks
maintained their effective sensitivity toward sarcosine.
While limited in number, literature reports of other sarcosine sensors exist and it is
important to place the sensor developed herein in context. A table summary of the performance of
the complete optimized system (Pt/COOH–SWCNT–CS/SOx/Nafion) and comparison of these
properties to other related literature reports of sarcosine or sarcosine–related sensors is provided
in Supporting Information (Table SI–3). The collective sensing performance of the optimized
sensor in this study is comparable with other sarcosine sensors in the literature, equaling or
exceeding standard sensing parameters such as sensitivity, linear sensing range, response time, and
limit of detection, though details of how the latter parameters were measured are not easily
ascertained in some reports. Few reports offer as rigorous evaluation of selectivity or as
18
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conservative of a response time measurement or shelf–life evaluation - all critically important to
eventual application. Additionally, this study takes the additional step to transition the sensing
capability to biological matrices (see below).
During the course of the study, exploration of different combinations of the materials and
deposition strategies uncovered minor alterations in biosensor construction that modestly, but
significantly, improved the sarcosine sensitivity. First, it was found that the initial layering of CS,
followed

by

the

deposition

of

COOH–SWCNTs,

designated

as

Pt/CS/COOH–

SWCNT/SOx/Nafion, as opposed to depositing a pre-made mixture of the two materials,
designated Pt/CS-COOH-SWCNT/SOx/Nafion, increased sarcosine sensitivity by ~30% (see
Table SI-3, Supporting Information). No other specific layering of the materials resulted in a
similar enhancement of the signal (Supporting Information, Fig. SI–6, Table SI–3). This result
suggests that the proximity or bridging of the SWCNTs between SOx and the CS layer is critical.
In addition to this specific layering effect, doping the outer Nafion layer with additional enzyme
also enhanced sensor signal as has been observed in other reports [27]. This effect is illustrated in
comparing the same systems with and without SOx doped Nafion (Supporting Information, Fig.
SI-10). The highest sustained observed sarcosine sensitivity (0.40 to 0.50 µA/mM) was recorded
with films incorporating both of these alterations (i.e., Pt/CS/COOH–SWCNT/SOx/Nafion*,
where the asterisk indicates additional doping with SOx – see Table SI-3) – a system subsequently
employed for critical sarcosine measurements of the study, including those made in biological
fluids such as urine (see below).

3.5. Biosensor Operation in Bodily Fluids
The specific medical application of the presented sensors will depend on the ultimate goal
of the diagnosis. For example, in detecting sarcosine as an early indication for prostate cancer,
sensor functionality in urine samples and the ability to respond to abnormal concentrations of
sarcosine (>20 µM) is required [46]. In order to evaluate the applicability of the developed
electrochemical biosensor for such an application, sensors were tested in synthetic urine media
and sarcosine-spiked urine samples were quantitatively assessed. Figure 6 shows the calibration
curve derived from I-t responses during sarcosine injections of a number of electrodes with
Pt/CS/COOH–SWCNT/SOx/Nafion films in buffer. The sensitivity of the response is as expected,
19
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but when this calibration curve is used to assess a synthetic urine test sample, which has been
spiked with 1.5 mM sarcosine, the average detection of sarcosine by the sensor is only 0.19 (±0.13)
mM both with and without background (charging current) correction. The severely depressed
measurement of the spiked sample suggests detrimental matrix effects that can be corrected for by
matrix matching the calibration. The same film constructs, calibrated in synthetic urine (Fig. 6)
resulted in relative lower sensitivity but more quantitative accuracy when inserted into the
sarcosine-spiked sample of synthetic urine (1.5 mM). The sensor exhibited a well-defined
amperometric step (Supporting Information, Fig. SI-11 and 12), a response that translated against
the calibration curve with much more accurate sarcosine concentration determination of 1.42
(±0.13) mM and 1.35 (±0.9) mM before and after charging current correction, respectively. This
result establishes effective percent recovery (≥ 90% in both cases) as well as low relative percent
error (~ 5%).
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Figure 6: Calibration curves obtained from amperometric
I-t curves during successive 0.25 mM injections of
sarcosine at Pt/CS/COOHSWCNT/SOx/Nafion (3%) in
(a) 4.4 mM potassium phosphate buffer (pH 7; n = 4)
compared to (b) synthetic urine (n = 4), and (c) variable
injections of 50 mM sarcosine at Pt/CS/COOHSWCNT/SOx/Nafion*(3%) in synthetic urine (n = 5);
Inset: Example of amperometric response to 20, 40, and
90 μM sarcosine spiked synthetic urine samples at
Pt/CS/COOHSWCNT/SOx/Nafion*(3%).
Notes:* indicates that the layer is doped with additional
SOx; In some cases, standard error bars are smaller than
markers for average value; Calibration curve (c) shown in
Supporting Information.
.

Based on prior successful enhancement of signal, the same system with an additional
doping of SOx into the outer Nafion layer (Pt/CS/COOH–SWCNT/SOx/Nafion*) was also tested
in synthetic urine. As shown in Figure 6, the enhancement is readily apparent in this media as well
with the improved slope of the calibration curve (Supporting Information, Fig. SI-13). In order to
be a clinically relevant sensor for prostate cancer diagnosis via urine analysis, the sarcosine sensors
need to be accurate at micromolar concentrations of sarcosine (≥ 20 µM). As a proof-of-concept
experiment, sensors were used to measure the sarcosine concentration of a limited number of
spiked synthetic urine samples at 20, 40, and 90 µM. All three concentrations were easily detected
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by the Pt/CS/COOH–SWCNT/SOx/Nafion* sensors during the I-t scan with representative results
shown in Fig. 6 (inset). In general, the sensors performed admirably, effectively quantifying the
sarcosine in the more complex matrix at micromolar levels (Table 1). The results of using sensors
in spiked synthetic urine samples show that, for most samples, high percent recovery and low
relative error were achieved on a significant number of sensors.

Table 1. Sensor Performance in Sarcosine Spiked Samples of Synthetic Urine

(Pt/CS/COOH-SWCNT/SOx/Nafion*)
Sarcosine-Spiked
Measured
Urine Sample
Sarcosine
n
Average %
Concentration
Concentration
Recovery
(µM)
(µM)
20
19.7 (±0.9)
9
98.5
40
41 (±2)
7
102.5
90
94 (± 9)
3
104.4

Average %
Relative Error
-1.5%
+2.5%
+4.4%

Notes: * Indicates a layer doped with additional SOx; Uncertainty represents standard deviation.

While being uniquely suited for incorporation into sarcosine detection platforms, such as
the one we have presented, SOx is also widely utilized in creatinine detection systems. Creatinine
represents an analyte that has been targeted for the diagnosis of, among other diseases, impending
renal failure and muscle degradation [4]. Creatinine biosensor designs have found success with a
tri–enzymatic cascade reaction involving creatininase (CI), creatinase (CA), and SOx [25, 26, 30]:
Creatinine + H2O –CI → Creatine
Creatine + H2O –CA → Sarcosine + Urea

(4)

Sarcosine + H2O + O2 –SOx → H2O2 + Formaldehyde + Glycine

It follows then that the versatility of any developed sarcosine biosensing scheme will be inherently
linked to its ability to function within a creatinine biosensor, ultimately affecting the significance
of the sensor development. Ideally, an electrode featuring this tri–enzyme cascade would be
operational in blood or blood serum, allowing for a potential in vitro diagnostic tool. Although
blood testing requires more considerations, such as accounting for additional natural and artificial
interferents (e.g., uric acid, acetaminophen, respectively), the higher relevant concentrations of
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creatinine indicative of nephron malfunction (>1 mM) is amenable to the sensor developed in this
study [50]. Here, we report the adaptation of our sarcosine biosensing scheme to be a functional
component of the tri–enzymatic scheme for creatinine. Essentially, the enzymatic layer of our
scheme replaces the SOx layer with a layer of combined SOx, creatinase, and creatininase enzymes
(Scheme II). Prior to being incorporated into the scheme, all enzymes were tested for activity

Pt

Sarcosine Oxidase
Creatinase
Creatininase

Pt

Drop casting

Nafion
Drop casting
Pt
2e -

Creatinine
Chitosan
Drop casting

Pt

Pt

2eH2O + O2
Glycine +
Formaldehyde

Scheme 2: Schematic representation of the LbL creatinine biosensing scheme featuring the
sarcosine sensor as a functional component.

with a fluorometric assay (Supporting Information, Fig. SI-14). The tri-enzyme combination was
deposited on Pt/CS/COOH-SWCNT interfaces and capped with Nafion before testing for
creatinine sensitivity in phosphate buffer. Figure 7 shows the system was clearly responsive to
creatinine injections in buffer (0.04 μA/mM) while the same experiment, conducted in blood
serum, yielded significantly attenuated creatinine sensitivity (0.008 μA/mM), the same type of
sensitivity depression observed for the sarcosine sensor when the testing media was changed from
buffer to urine (Fig. 6). With the sarcosine/urine testing, manipulation of the outermost semipermeable membrane resulted in an improved signal-to-noise ratio and ultimately improved
sensitivity in that matrix. Biosensor schemes utilizing other types of materials such as sol-gels
have established that the introduction of a diffusional layer often achieves better sensor
22
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performance, including lower noise, greater sensitivity, and lower limits of detection [13, 14, 49].
A similar effect is observed here with the creatinine system when an additional, outer diffusional
layer of CS (Scheme 2). Adding the additional CS layer resulted in significant enhancement of
the creatinine sensor performance in buffer, including a creatinine sensitivity of 0.57 µA/mM (not
shown in Fig. 7, see Supporting Information, Table SI-3). The enhancement of the performance
with the outer CS layer then allowed for the sensor to maintain effective sensitivity when immersed
in blood serum (Fig. 7c). serves to lower noise, significantly improving sensitivity back to 0.04
μA/mM, and allowing for a low limit of detection (0.20

±0.08 mM) and spanning the

physiologically relevant creatinine concentrations for disease diagnosis (~ 1 mM).

a
b

a

c

c

b

Figure 7: Calibration curves obtained from
amperometric I-t curves during successive 0.25 mM
injections of creatinine at Pt/CS-COOH-SWCNT/CI-CASOx/Nafion in (a) 4.4 mM potassium phosphate buffer
(pH 7) and (b) blood serum; (c) the same system with an
additional CS capping layer (Pt/CS-COOH-SWCNT/CICA-SOx/Nafion/CS) tested in blood serum (buffer
response of CS capped system not shown). Note: Solid
symbol markers indicate a step-like response (n = 3-6);
Inset: Corresponding examples of amperometric steps to
0.25 injections of creatinine from the three systems.

The reason for the improved performance achieved with the CS capping layer is not fully
understood but, as with other diffusional layers in biosensing schemes [13, 14, 49], the CS layer
may be effectively gating the approach and partition of creatinine and/or oxygen into the film and
allowing the enzymes to avoid saturation effects. It is also possible that the chitosan may provide
additional discrimination against interferents simply improving signal-to-noise. A creatinine
calibration curve was collected in blood serum and used to quantify 0.75 mM and 1.0 mM
creatinine spiked samples. A typical I-t curve, the step current responses of the spiked samples,
and a representative calibration curve are included in Supporting Information (Fig. SI-15). The
0.75 mM and 1.0 mM creatinine spiked solutions were determined to contain 0.765 mM and 1.07
mM creatinine, respectively, both under 10% relative error with high (100-110%) percent recovery
on a limited number of tests. The demonstrated functionality of the scheme in blood serum at
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clinically relevant concentrations of creatinine is in line with further development of the system
toward in vitro testing as a medical diagnosis tool.

4. Conclusion
In this work, we have presented a functional LbL electrochemical biosensing scheme for
the effective detection of sarcosine as well as a functional component of a creatinine sensor, both
systems applicable for numerous clinical diagnoses. The demonstrated LbL approach of this study
allows for individual shortcomings of the materials to be overcome, such as the non–conductivity
of chitosan and the non–solubility of CNTs. The sensing performance of our system is comparable
to other electrochemical schemes with optimization showing that the system has a linear range of
detection throughout relevant concentrations, selectivity against interfering molecules, a shelf life
amenable to actual clinical application, and successful performance in bodily fluids. The presented
biosensing scheme is versatile and robust, allowing additional measures to be applied for greater
sensitivity, including signal enhancement via the addition of platinum black modified electrodes
[14] and nanoparticle networks [33]. While effective, non-electrochemical sarcosine sensors,
some requiring significant materials preparation and intricate fabrication (e.g., nanoparticles [10],
quantum dots [51]) as well as complex instrumentation [7], amperometric biosensors continue to
maintain advantages of simplicity, cost-effectiveness, and versatility. In the latter regard,
electrochemical biosensors of this nature can be adapted to microelectrodes for real-time operation
at the patient’s bedside [52] or detection of sarcosine in delicate brain tissue, as would be required
if used for schizophrenia and depression diagnoses [2,3]. As such, the presented biosensing
scheme and the greater understanding of the materials used in the strategy, demonstrate a sensor
design poised for further research and a promising candidate for clinical application development.
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